Foghorn Therapeutics
(NASDAQ) FHTX
Foghorn Therapeutics Financials at a Glance
Market Cap
$310.52M
Revenue (TTM)
$30.91M
Net Income (TTM)
$74.28M
EPS (TTM)
$-1.22
P/E Ratio
-4.34
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$5.30
Volume
7,974
Open
$4.97
Price
$5.30
Volume
7,974
Open
$4.97
Previous Close
$5.30
Daily Range
$4.97 - $5.30
52-Week Range
$3.27 - $6.95
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$5.30
Volume
7,974
Open
$4.97
Previous Close
$5.30
Daily Range
$4.97 - $5.30
52-Week Range
$3.27 - $6.95
FHTX News
FHTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Foghorn Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
106
CEO
Adrian Gottschalk, MBA
Website
www.foghorntx.comHeadquarters
Cambridge, MA 02139, US
FHTX Financials
Key Financial Metrics (TTM)
Gross Margin
30%
Operating Margin
-3%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
-59%
Return on Assets
-37%
Earnings Yield
-23.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$310.52M
Shares Outstanding
58.70M
Volume
7.97K
Short Interest
0.00%
Avg. Volume
161.37K
Financials (TTM)
Gross Profit
$27.58M
Operating Income
$82.11M
EBITDA
$78.78M
Operating Cash Flow
$86.10M
Capital Expenditure
$50.00K
Free Cash Flow
$86.15M
Cash & ST Invst.
$158.89M
Total Debt
$41.27M
Foghorn Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.25M
+223.8%
Gross Profit
$8.45M
+195.7%
Gross Margin
91.33%
N/A
Market Cap
$310.52M
N/A
Market Cap/Employee
$2.77M
N/A
Employees
112
N/A
Net Income
$21.66M
-11.1%
EBITDA
$18.79M
+19.1%
Quarterly Fundamentals
Net Cash
$117.62M
-43.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$40.35M
+43.8%
Short Term Debt
$923.00K
-89.8%
Return on Assets
-37.50%
N/A
Return on Invested Capital
-59.34%
N/A
Free Cash Flow
$22.27M
+10.9%
Operating Cash Flow
$22.27M
+9.2%